Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms

Infection Control and Hospital Epidemiology

Volumn 35, Issue 11, 2014, Pages 1427-1429

  Birgand, Gabriel ^a,b,c   Schwarzinger, Michael ^a,b   Perozziello, Anne ^c   Lolom, Isabelle ^c   Pelat, Camille ^a,b   Armand Lefevre, Laurence ^c   Buzzi, Jean Claude ^c   Andremont, Antoine ^c   Yazdanpanah, Yazdan ^a,b,c   Lucet, Jean Christophe ^a,b,c  

^a UNIVERSITÉ PARIS DIDEROT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BACTERIAL COLONIZATION; CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE; CASE CONTROL STUDY; CONTROLLED STUDY; ENTEROCOCCUS; FEMALE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NOTE; SCREENING; ANTIBIOTIC RESISTANCE; DIAGNOSIS; DISEASE TRANSMISSION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FRANCE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH CARE POLICY; HETEROZYGOTE; INFECTION CONTROL; LEGISLATION AND JURISPRUDENCE; MIDDLE AGED; PREVENTION AND CONTROL; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TRANSMISSION; UNIVERSITY HOSPITAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARRIER STATE; CASE-CONTROL STUDIES; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENTEROCOCCUS; FEMALE; FRANCE; GRAM-POSITIVE BACTERIAL INFECTIONS; HEALTH POLICY; HOSPITALS, UNIVERSITY; HUMANS; INFECTION CONTROL; LENGTH OF STAY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84908353321     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1086/678425     Document Type: Note

References (10)

1. Canton R, Akova M, Carmeli Y, et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012;18:413-431.
2. European Centre for Disease Prevention and Control (ECDC). Carbapenemase-producing bacteria in Europe: Interim results from the European survey on carbapenemase-producing Enterobacteriaceae (EuSCAPE) project 2013. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-carbapenemase-producing-bacteria-europe.pdf. Accessed June 13, 2014.
3. ECDC. Antimicrobial resistance surveillance in Europe. http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-resistance-carbapenemase-producing-bacteria-europe.pdf. Accessed June 13, 2014.
4. Haut Conseil de la Sante Publique. Prevention de la transmission croisee des Bacteries Hautement Resistantes aux antibiotiques emergentes (BHRe). http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=372. Accessed June 13, 2014.
5. Agence Technique de l’Information sur l’Hospitalisation. Echelle nationale de couts par GHM (en euros), referentiel national de couts. 2011. http://wwwatihsantefr/. Accessed June 13, 2014.
6. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992;13:606-608.
7. European Center for Disease Prevention And Control. Antimicrobial resistance interactive database (EARS-Net). http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx. Accessed June 13, 2014.
8. Fournier S, Brun-Buisson C, Jarlier V. Twenty years of antimicrobial resistance control programme in a regional multi-hospital institution, with focus on emerging bacteria (VRE and CPE). Antimicrob Resist Infect Control 2012;1:9.
9. Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 37, 85–93 (2009).
10. Birgand G, Ruimy R, Schwarzinger M, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control 2013;2:30.